Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Personalis (PSNL)

Personalis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DateTimeSourceHeadlineSymbolCompany
08/05/202421:01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
08/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
24/04/202421:01Business WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/03/202420:01Business WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
28/03/202413:00Business WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
26/03/202413:00Business WirePersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response MonitoringNASDAQ:PSNLPersonalis Inc
19/03/202420:43Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
28/02/202421:01Business WirePersonalis Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/02/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
14/02/202421:01Business WirePersonalis to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
31/01/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
31/01/202421:01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
30/01/202414:00Business WirePersonalis and ClearNote Health Announce Partnership to Advance Epigenomic TechnologyNASDAQ:PSNLPersonalis Inc
29/01/202421:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PSNLPersonalis Inc
17/01/202421:15Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
16/01/202414:05Business WirePersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling AssayNASDAQ:PSNLPersonalis Inc
10/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
09/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
05/01/202414:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
05/01/202414:05Business WirePersonalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash BalanceNASDAQ:PSNLPersonalis Inc
21/12/202322:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
21/12/202322:12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
19/12/202323:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
19/12/202323:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/12/202321:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/12/202321:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PSNLPersonalis Inc
04/12/202314:15Business WirePersonalis Extends Cash Position Into 2026, Provides Update on Key InitiativesNASDAQ:PSNLPersonalis Inc
01/12/202321:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
28/11/202321:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
28/11/202321:15Business WirePersonalis and Tempus Enter into a Strategic Collaboration to Advance Cancer TestingNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL